Leniolisib
| CAS No. | 1354690-24-6 |
|---|---|
| MDL No. | MFCD30470232 |
| MF | C21H25F3N6O2 |
| MW | 450.50 |
| InChI Key | MWKYMZXCGYXLPL-ZDUSSCGKSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Leniolisib is a pyridopyrimidine with a 5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine core substituted at positions 4 and 6 by [(3S)-1-propanoylpyrrolidin-3-yl]amino and 6-methoxy-5-(trifluoromethyl)pyridin-3-yl groups, respectively. It functions as an EC 2.7.1.153 (phosphatidylinositol-4,5-bisphosphate 3-kinase) inhibitor and an immunomodulator. It is an aromatic ether, a pyridine, an organofluorine compound, a secondary amino compound, a pyrrolidine, and a tertiary carboxamide.
| CAS No. | 1354690-24-6 |
|---|---|
| Product Name | Leniolisib |
Biological Targets
PIK3CD
Associated Conditions
neoplasm·common variable immunodeficiency·Sjogren syndrome·inborn error of immunity
* The information provided here is compiled from public sources and is for reference only.
